FDA informs gene-drug associations, and Quest Diagnostics uses Coriell Life Sciences for personalized reports.
1 report, 1 independent
Updated Sep 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA informs gene-drug associations, and Quest Diagnostics uses Coriell Life Sciences for personalized reports.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Quest Diagnostics
medical research company
Related events
- The FDA requested additional clinical data from Unicycive Therapeutics.
- FDA placed a clinical hold on a gene therapy involving Hunter.
- The FDA has questioned promotional materials related to an investigational drug from Alar Pharmaceuticals.
- FDA approval enables commercial opportunity involving CBRE Group.
- The FDA approved various advanced therapies, including oral medication from Roche, a gene-targeting drug from Biogen, and a one-time gene therapy from Novartis.
Coverage
Newest first; wire copies grouped- Medical Device NetworkQuest Diagnostics introduces new pharmacogenomic testing service Quest Diagnostics has introduced a new pharmacogenomic (PGx) laboratory testing service designed to assist healthcare providers in und